Bioventus Inc. - SIC # 3850 -

Ticker Exchange SIC # Website Latest Ticker
BVS Nasdaq 3850 www.bioventus.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bioventus Inc.

Do Options Traders Know Something About Bioventus Stock We Don't? - Jun 13th, 2025 6:30 am
Bioventus First Quarter 2025 Earnings: EPS Beats Expectations - May 7th, 2025 5:11 am
Bioventus Inc (BVS) Q1 2025 Earnings Call Highlights: Navigating Growth Amidst Divestitures - May 7th, 2025 1:09 am
Bioventus (BVS) Q1 Earnings and Revenues Surpass Estimates - May 6th, 2025 6:45 am
Bioventus: Q1 Earnings Snapshot - May 6th, 2025 5:50 am
Bioventus Reports First Quarter Financial Results - May 6th, 2025 5:30 am
Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025 - Apr 28th, 2025 6:00 am
Bioventus Inc. (NASDAQ:BVS) On The Verge Of Breaking Even - Apr 22nd, 2025 5:07 am
Here's Why Bioventus (BVS) Is a Great 'Buy the Bottom' Stock Now - Mar 31st, 2025 7:55 am
Bioventus (BVS) Upgraded to Buy: Here's What You Should Know - Mar 17th, 2025 10:00 am
Bioventus Full Year 2024 Earnings: Beats Expectations - Mar 12th, 2025 5:02 am
Bioventus Inc (BVS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Debt ... - Mar 12th, 2025 1:04 am
Bioventus (BVS) Q4 Earnings and Revenues Surpass Estimates - Mar 11th, 2025 6:45 am
Bioventus: Q4 Earnings Snapshot - Mar 11th, 2025 5:52 am
Bioventus Announces Fourth Quarter and Full Year 2024 Financial Results - Mar 11th, 2025 5:30 am
Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025 - Feb 28th, 2025 5:30 am
Recursion Pharmaceuticals (RXRX) Stock Jumps 8.9%: Will It Continue to Soar? - Feb 13th, 2025 3:19 am
With 32% ownership, Bioventus Inc. (NASDAQ:BVS) has piqued the interest of institutional investors - Jan 31st, 2025 4:58 am
Bioventus to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Jan 7th, 2025 6:00 am
BVS Stock Gains Post Divestiture of Advanced Rehabilitation Business - Jan 3rd, 2025 8:53 am